syngeneic lymphocytes cultured with okt3 and interleukin-2
Cell therapyexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 1996 (NCT00001535)
Timeline
1990s
- Jan 1, 1996
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetImmunity, passive
immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- syngeneic lymphocytes cultured with okt3 and interleukin-2
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00001535 | Phase 1 | Mar 1, 1996 | National Human Genome Research Institute (NHGRI) |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Human Genome Research Institute (NHGRI) | Government | 1 | 1 | 1 | 1996 |
1 organizations
Page 1 / 1